Form 4: Viking Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Brian Lian, President & CEO and a Director of Viking Therapeutics, Inc., sold 148,517 shares of common stock on July 28, 2026 for $33.32 per share.
Summary
- Grant/award: acquired 221,667 Common Stock, par value $0.00001 per share on July 28, 2026; holds 2,720,958 after (Direct).
- Open-market sale: disposed of 148,517 Common Stock, par value $0.00001 per share at $33.32 ($4,947,888) on July 29, 2026; holds 2,572,441 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $4,947,888 of stock on the open market.
Insider Transactions
Brian Lian — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Grant/award | Common Stock, par value $0.00001 per share | 221,667 | — | — | 2,720,958 |
| 2026-07-29 | Open-market sale | Common Stock, par value $0.00001 per share | 148,517 | $33 | $4.9M | 2,572,441 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Grant/award (221,667 shares) |
| 2026-07-29 | Open-market sale (148,517 shares) |
Keywords
insider transaction, Form 4, VKTX, Viking Therapeutics, Inc., bearish, Brian Lian
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.